- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lexaria Bioscience Corp (LEXX)
Track the Lexaria Bioscience share price today and view real-time LEXX share price data, including charts, technicals, and key financials. View the LEXX premarket stock price ahead of the market session or assess the after hours quote. Explore LEXX stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Lexaria Bioscience Stock Price Today?
The Lexaria Bioscience stock price today is 3.670.
What Is the Stock Symbol for Lexaria Bioscience?
The stock symbol for Lexaria Bioscience is ""LEXX.""
What Stock Exchange Does Lexaria Bioscience Trade On?
Lexaria Bioscience is listed and trades on the NASDAQ stock exchange.
Is Lexaria Bioscience a Good Stock to Buy?
Determining whether Lexaria Bioscience or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LEXX quote. (ISIN: US52886N6040)
What Is the Lexaria Bioscience Stock Price Today?
The Lexaria Bioscience stock price today is 3.670.
What Is the Stock Symbol for Lexaria Bioscience?
The stock symbol for Lexaria Bioscience is ""LEXX.""
What Stock Exchange Does Lexaria Bioscience Trade On?
Lexaria Bioscience is listed and trades on the NASDAQ stock exchange.
Is Lexaria Bioscience a Good Stock to Buy?
Determining whether Lexaria Bioscience or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LEXX quote. (ISIN: US52886N6040)
3.670
+0.370(+11.21%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.300
3.680
52 wk Range
0.560
21.600
LEXX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.3003.680
52 wk Range
0.56021.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LEXX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
28/10/2026
EPS / Forecast
-- / -0.06
Revenue / Forecast
-- / --
Compare LEXX to Peers and Sector
Metrics to compare | LEXX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLEXXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −2.4x | −0.3x | |
PEG Ratio | −0.02 | 0.00 | 0.00 | |
Price/Book | 1.6x | 1.3x | 2.6x | |
Price / LTM Sales | 38.1x | 1.7x | 2.9x | |
Upside (Analyst Target) | - | 59.8% | 60.1% | |
Fair Value Upside | Unlock | 8.5% | 8.3% | Unlock |
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company’s DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Lexaria Bioscience (LEXX) Stock Price Today?
The Lexaria Bioscience stock price today is 3.670 USD.
What Stock Exchange Does Lexaria Bioscience Trade On?
Lexaria Bioscience is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Lexaria Bioscience?
The stock symbol for Lexaria Bioscience is "LEXX."
What Is the Lexaria Bioscience Market Cap?
As of today, Lexaria Bioscience market cap is 7.730M USD.
What Is Lexaria Bioscience's Earnings Per Share (TTM)?
The Lexaria Bioscience EPS (TTM) is -5.14.
From a Technical Analysis Perspective, Is LEXX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Lexaria Bioscience Stock Split?
Lexaria Bioscience has split 4 times.
How Many Employees Does Lexaria Bioscience Have?
Lexaria Bioscience has 7 employees.
What is the current trading status of Lexaria Bioscience (LEXX)?
As of 29/10/2026, Lexaria Bioscience (LEXX) is trading at a price of 3.670 USD, with a previous close of 3.300 USD. The stock has fluctuated within a day range of 3.300 USD to 3.680 USD, while its 52-week range spans from 0.560 USD to 21.600 USD.
What Is Lexaria Bioscience (LEXX) Price Target According to Analysts?
The average 12-month price target for Lexaria Bioscience is 82.500 USD, with a high estimate of 82.49996 USD and a low estimate of 82.49996 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +2,147.96% Upside potential.
What Is the LEXX Premarket Price?
LEXX's last pre-market stock price is 3.348 USD. The pre-market share volume is 80.000, and the stock has decreased by 0.048, or 1.450%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.